Startseite Naturwissenschaften BOX A-type monopyrrolic heterocycles modified via the Suzuki-Miyaura cross-coupling reaction
Artikel Öffentlich zugänglich

BOX A-type monopyrrolic heterocycles modified via the Suzuki-Miyaura cross-coupling reaction

  • Daniel Schulze , Maurice Klopfleisch , Helmar Görls und Matthias Westerhausen EMAIL logo
Veröffentlicht/Copyright: 20. November 2019
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

The in vivo oxidation of heme yields bilirubin which is further degraded to the bilirubin oxidation end products (BOXes) that are biologically highly active. To study the mode of action and fate of (Z)-2-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (BOX A), the Suzuki-Miyaura cross-coupling reaction allows to introduce various alkenyl- and aryl-substituents in 3-position of the (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetamides (BOX A-type monopyrroles). The influence of these groups on structural and NMR-spectroscopic parameters of the central monopyrrolic system is negligible. Special focus has been given to derivatives with 3-positioned aryl substituents carrying trifluoromethyl groups for future in vivo19F NMR studies.

1 Introduction

In vivo oxidative heme degradation is catalyzed by heme oxygenases or by reactive oxygen species (ROS) leading to a stepwise degradation via bilirubin and biliverdin. These metabolites are further oxidatively degraded to dipyrrolic propentdyopent-type species (PDPs) and finally to the monopyrrolic birubin oxidation end products (BOXes) [1], [2], [3], [4], [5]. The concentration of the BOXes in human bile depends on the structure and is very low (0.1 μm for BOX C and 0.5 μm for BOXes A and B, Scheme 1) [6], [7]. The presence of an isomer of BOX C (BOX D: R1=Me, R2=CH2CH2COOH) has not been detected yet in human bile. The interest in these degradation end products arises from their biological activity, especially a long-lasting narrowing of cerebral blood vessels, and the assumption that these compounds play a significant role in subarachnoid hemorrhage which is responsible for 5% of all strokes with high morbidity and mortality [8].

Scheme 1: The bilirubin degradation end products (BOXes A, B, C, and D) are metabolites of the oxidative degradation of heme via bilirubin and propentdyopents. Only BOXes A, B, and C have been detected in human bile up to now.
Scheme 1:

The bilirubin degradation end products (BOXes A, B, C, and D) are metabolites of the oxidative degradation of heme via bilirubin and propentdyopents. Only BOXes A, B, and C have been detected in human bile up to now.

Due to the very low concentrations it is extremely challenging to isolate these BOXes from biological or medicinal tissues and to elucidate fate and mode of action of these derivatives in vivo. The oxidative in vitro degradation of bilirubin with hydrogen peroxide in highly alkaline solution yields BOXes A [9], B [9] and C [10] with extremely poor yields allowing characterization of these derivatives but impeding studies with respect to biological activity and fate. Therefore we developed strategies for the total syntheses of these BOXes A [11], B [12], C and D [13] to elucidate their effects on biological tissues [7], [9], [14], [15], [16]. Here we report our investigation on the Suzuki-Miyaura cross-coupling reaction to modify the substitution pattern of BOX A-type derivatives for labeling and future investigations on the influence of certain substituents on biological activity. The Suzuki-Miyaura cross-coupling is a well-studied reaction to catalytically form C–C bonds in diverse compounds ranging from organic to pharmaceutical and biochemical molecules and applications [17], [18], [19], [20], [21], [22], [23], [24].

2 Results and discussion

2.1 Synthesis of BOX A

The total synthesis of BOX A is a multi-step procedure involving the synthesis of methyl (Z)-2-(3-bromo-4-methyl-5-oxofuran-2(5H)-ylidene)acetate (1) [11]. During conversion of 1 to methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) via reaction with ammonium acetate in glacial acetic acid, intermediately formed and hitherto unknown methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2) could be isolated (Scheme 2). In order to avoid mixtures of 2 and 3, prolonged reaction time of 6 h and a temperature of 120°C were mandatory to quantitatively convert 1 to 3 without the necessity to isolate intermediate 2. The Suzuki-Miyaura cross-coupling reaction proved to be a suitable method to substitute the bromo functionality of 3 with potassium vinyl-trifluoroborate (4a) by a vinyl group yielding methyl (Z)-2-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (R=CH=CH2, 5a). Here we studied the scope of the Suzuki-Miyaura cross-coupling reaction to also attach aromatic hydrocarbyl groups or propenyl substituents. Thereafter, conversion of the ester functionality into an carboxylic amide via the carboxylic acid (6a) and the corresponding acid chloride (7a) yielded (Z)-2-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (BOX A, R=CH=CH2, 8a). This reaction sequence is depicted in Scheme 2.

Scheme 2: The reaction sequence for the total synthesis of BOX A-type compounds 8. BOX A (R=CH=CH2, 8a) is a metabolite of the oxidative degradation of bilirubin.
Scheme 2:

The reaction sequence for the total synthesis of BOX A-type compounds 8. BOX A (R=CH=CH2, 8a) is a metabolite of the oxidative degradation of bilirubin.

The molecular structure and atom labeling scheme of methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2) are depicted in Fig. 1. Due to a centric space group the crystalline phase consists of a racemate of this chiral compound. Within the five-membered heterocycle significantly different C–C bond lengths are observed, excluding effective charge delocalization between the carbonyl fragment C5–O51 and the C3=C4 double bond. The N1–C2 bond is more than 10 pm longer than the N1–C5 bond. This elongation is a consequence of sp3 hybridization of C2 and a rather crowded environment of this quaternary carbon atom. Therefore it is not astonishing that the C2–C3 and C2–C21 bond lengths are larger than the C4–C5 and C4–C41 single bonds.

Fig. 1: Molecular structure and atom labeling scheme of methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2, top). The ellipsoids represent a probability of 30%. Hydrogen atoms are shown with arbitrary radii. Selected bond lengths (pm): N1–C5 135.0(2), C4–C5 149.3(2), C3–C4 133.2(2), C2–C3 152.3(2), N1–C2 145.8(2), N1–H1 83(2), C5–O51 123.5(2), C4–C41 148.3(2), C3–Br31 186.54(16), C2–O26 139.8(2), O26–H26 82(3), C2–C21 153.9(2), C21–C22 150.5(2), C22–O23 120.8(2), C22–O24 133.5(2), O24–C25 145.0(2). At the bottom, aggregation via hydrogen bonds is depicted. The atoms are shown with arbitrary radii, hydrogen atoms are omitted for clarity reasons.
Fig. 1:

Molecular structure and atom labeling scheme of methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2, top). The ellipsoids represent a probability of 30%. Hydrogen atoms are shown with arbitrary radii. Selected bond lengths (pm): N1–C5 135.0(2), C4–C5 149.3(2), C3–C4 133.2(2), C2–C3 152.3(2), N1–C2 145.8(2), N1–H1 83(2), C5–O51 123.5(2), C4–C41 148.3(2), C3–Br31 186.54(16), C2–O26 139.8(2), O26–H26 82(3), C2–C21 153.9(2), C21–C22 150.5(2), C22–O23 120.8(2), C22–O24 133.5(2), O24–C25 145.0(2). At the bottom, aggregation via hydrogen bonds is depicted. The atoms are shown with arbitrary radii, hydrogen atoms are omitted for clarity reasons.

In the crystalline state methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2) aggregates via intermolecular N1–H1⋯O23′ hydrogen bonds to the ester carbonyl moieties of the neighboring molecule (−x, y, −z+0.5). Furthermore, the hydroxyl group forms an O26–H26⋯O51′ hydrogen bond to the carbonyl group of the nearby oxopyrrole fragment (−x, −y, −z). Both hydrogen bonds are nearly linear with N1–H1⋯O23′ and O26–H26⋯O51′ bond angles of 170(2)° and 172(3)° and N1⋯O23′ and O26⋯O51′ distances of 295.81(17) and 275.58(16) pm, respectively. This hydrogen bonding network leads to the formation of a strand structure in the solid state (Fig. 1, bottom).

2.2 Suzuki-Miyaura cross-coupling

The Suzuki-Miyaura cross-coupling step offers the opportunity to introduce groups other than the vinyl moiety. This alteration allows to bind substituents with functionalities that allow tracking of these monopyrrolic compounds in living organisms (such as 19F-containing groups for 19F{1H} NMR spectroscopic experiments). Therefore we studied the scope of this C–C bond forming reaction between sp2-hybridized carbon atoms that in general gave excellent isolated yields above 80%. In a typical procedure, methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) and 1.5 equivalents of the corresponding potassium aryl- or alkenyl-trifluoroborate (4b4k, 1.5 mmol, 1.5 equiv.) were dissolved in a solvent mixture of tetrahydrofuran and water (ratio 4:1) in the presence of 5 mol-% of Pd(PPh3)2Cl2 and three equivalents of CsF. Then the reaction mixture was heated under reflux for 18 h in a nitrogen atmosphere. In all cases the Z-isomeric form was isolated because this diastereomer is stabilized via formation of an intramolecular N–H⋯O hydrogen bond between the pyrrole unit and the ester carbonyl functionality. The outcome of this screening is summarized in Table 1.

Table 1:

Synthesis of 3-aryl- and 3-alkenyl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates (5a5k) viaSuzuki-Miyaura cross-coupling reactions using RBF3K (4a4k) according to Scheme 2.

EntryRProductYield (%)Ref.
1CH=CH2 (4a)5a84[11]
2(E)-CH=CH–CH3 (4b)5b90This work
3C(Me)=CH2 (4c)5c93This work
4C6H5 (4d)5d90This work
5C6H4-3-CH3 (4e)5e82This work
6C6H4-4-CH3 (4f)5f91This work
7C6H4-4-C(CH3)3 (4g)5g89This work
8C6H4-4-CF3 (4h)5h94This work
9C6H3-3,5-(CF3)2 (4i)5i98This work
102-naphthyl (4j)5j85This work
112-furanyl (4k)5k82This work

Due to the fact that 19F-labeled BOX A derivatives attracted our special interest, the molecular structure and the atom labeling scheme of methyl (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (5h) are depicted in Fig. 2. The molecular representations of the derivatives 5b5g and 5j are shown in the Supporting Information (available online) verifying that exclusively Z-isomeric congeners were isolated and crystallized.

Fig. 2: Molecular structure and atom labeling scheme of methyl (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (5h, top). The ellipsoids represent a probability of 30%, hydrogen atoms are drawn with arbitrary radii. Selected bond lengths (pm) are listed in Table 2. At the bottom, dimerization via intermolecular hydrogen bonds is depicted. All atoms are shown with arbitrary radii.
Fig. 2:

Molecular structure and atom labeling scheme of methyl (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (5h, top). The ellipsoids represent a probability of 30%, hydrogen atoms are drawn with arbitrary radii. Selected bond lengths (pm) are listed in Table 2. At the bottom, dimerization via intermolecular hydrogen bonds is depicted. All atoms are shown with arbitrary radii.

For comparison reasons selected structural parameters of 3-alkenyl- (entries 2 and 3) and 3-aryl-substituted (entries 4–9) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates 5 are listed in Table 2. The numbering of the carbon atoms obeys to the IUPAC recommendation as used for the atom denominations in these compounds. The bond lengths of all compounds deviate in a very narrow range with the phenyl (entry 4, 5d) and naphthyl derivatives (entry 9, 5j) showing the shortest C3=C4 double bonds and the longest C3–C31 and N1–C5 bonds. However, these differences are very small and in the order of the estimated standard deviations. In summary, the substituents in 3-position show a negligible influence on the structural parameters of the 3-alkenyl- (entries 2 and 3) and 3-aryl-substituted (entries 4–9) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates.

Table 2:

Selected bond lengths (pm) of 3-alkenyl- (entries 2 and 3) and 3-aryl-substituted (entries 4–9) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates (5a5j).

EntryComp.N1–C2C2–C3C3=C4C4–C5N1–C5C2=C21C3–C31C5=O51N1–H1Ref.
12145.8(2)152.3(2)133.2(2)149.3(2)135.0(2)153.9(2)186.54(16)c123.5(2)83(2)This work
25b138.9(2)149.2(2)135.8(2)148.1(2)137.4(2)134.6(2)145.6(2)122.6(2)91(2)This work
35c Aa138.0(2)148.5(2)133.9(2)149.1(2)138.8(2)134.5(2)148.2(2)121.6(2)86(2)This work
5c Ba138.4(2)148.0(2)134.3(2)149.2(2)137.7(2)134.5(2)148.7(2)121.6(2)86(2)
45d Aa138.1(2)148.1(2)134.6(2)149.1(2)137.8(2)134.7(2)147.8(2)122.1(2)90(2)This work
5d Ba138.4(2)148.5(2)134.6(2)148.5(2)138.0(2)134.7(2)147.6(2)122.1(2)88(2)
55e Aa138.6(2)148.5(2)135.1(2)148.4(2)137.5(2)134.5(2)147.8(2)122.6(2)87(2)This work
5e Ba138.2(2)148.3(2)135.2(2)148.7(2)137.6(2)134.2(2)147.6(2)122.3(2)84(2)
65f Ab138.1(3)148.8(3)134.2(4)148.9(3)138.1(3)134.6(4)148.3(3)122.0(3)85(3)This work
5f Bb139.1(3)148.5(3)135.0(3)148.8(3)137.8(3)134.6(4)148.0(3)122.0(3)90(3)
5f Cb138.6(3)148.3(3)134.8(3)148.9(3)137.3(3)134.8(3)147.6(3)122.5(3)86(3)
5f Db139.0(3)148.5(3)134.3(3)149.0(3)137.4(3)134.6(3)147.6(3)122.5(3)86(3)
75g138.7(2)148.1(2)134.6(2)149.5(2)137.9(2)134.2(2)148.4(2)121.9(2)88(2)This work
85h139.3(2)148.5(2)135.2(2)148.7(2)137.5(2)134.9(2)147.6(2)122.3(2)89(2)This work
95j139.1(2)148.1(2)134.5(2)148.5(2)137.8(2)135.0(2)147.6(2)122.2(2)89(2)This work
  1. For comparison, compound 2 (entry 1) is included. aThe asymmetric unit contains two molecules A and B. bThe asymmetric unit contains four molecules A, B, C, and D. cC3–Br31 bond length.

The 3-alkenyl- (entries 1 and 2, Table 3) and 3-aryl-substituted (entries 3–8) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates 5 form dimers in the crystalline state due to aggregation via intermolecular N1–H1⋯O51′ hydrogen bonds (Table 3). These highly asymmetric hydrogen bonds are rather weak and the intermolecular N1⋯O51′ distances adopt values between 290 and 320 pm. The N–H stretching vibrations show values around 3300 cm−1 supporting the weak nature of these hydrogen bonds. The N1–H1⋯O51′ bond angles adopt rather large values between 145° and 165°. At the bottom of Fig. 2, dimerization via intermolecular hydrogen bonds is depicted.

Table 3:

Selected bond lengths (pm) and angles (deg.) of the intermolecular hydrogen bonds of 3-alkenyl- (entries 1 and 2) and 3-aryl-substituted (entries 3–8) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates (5a5j).

EntryComp.N1–H1O51′⋯H1cN1⋯O51′cN1–H1⋯O51′cRef.
15b91(2)205(2)292.84(16)162(2)This work
25c Aa86(2)235(2)312.72(19)151(2)This work
5c Ba84(2)243(2)318.80(18)151.3(19)
35d Aa90(2)211(2)295.74(15)158.5(16)This work
5d Ba88(2)224(2)305.65(15)155.5(16)
45e Aa87(2)207(2)289.96(19)158.5(19)This work
5e Ba84(2)237(2)309.6(2)145.1(19)
55f Ab85(3)212(4)292.9(3)159(3)This work
5f Bb90(3)205(3)293.0(3)165(3)
5f Cb86(3)206(3)289.6(3)163(3)
5f Db86(3)213(3)294.6(3)159(3)
65g88(2)221(2)302.31(18)153(2)This work
75h89(2)206(2)290.56(18)158(2)This work
85j89(2)207(2)291.26(19)157(2)This work
  1. aThe asymmetric unit contains two molecules A and B. bThe asymmetric unit contains four molecules A, B, C, and D. cIntermolecular distances to the neighboring molecule.

2.3 Syntheses and molecular structures of BOX A-derived congeners

As outlined above, we were especially interested in the 19F labeled congeners for future studies on degradation and fate of the monopyrrolic compounds in biological systems. Therefore, we converted the ester functionalities of 5h and 5i with LiOH at T=0°C into the corresponding carboxylic acids yielding (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetic acid (6h) and (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetic acid (6i), respectively. An additional purification was not necessary, but the purity was then sufficient for the subsequent derivatization protocol. The reaction of these acids with oxalyl chloride at room temperature yielded the corresponding acetyl chlorides, (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetyl chloride (7h) and (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetyl chloride (7i) as depicted in Scheme 2. Finally, these compounds were dissolved in THF and ammonia was added at T=0°C. Then the reaction mixture was warmed to room temperature. Contrary to the yields of 6 and 7 which were excellent, the final step proceeded with yields of only 67% and 53% for (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8h) and (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8i).

The molecular structures and atom labeling schemes of 8h and 8i are depicted in Figs. 3 and 4. The crystal structure of 8h contains two crystallographically independent molecules A and B with very similar structural parameters and an additional methanol molecule which is involved in an extended hydrogen bonding network.

Fig. 3: Molecular structure and atom labeling scheme of (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8h, top). The ellipsoids represent a probability of 30%, hydrogen atoms are shown with arbitrary radii. At the bottom, aggregation via hydrogen bonds (dotted lines) is shown. Only the non-hydrogen atoms are drawn with arbitrary radii.
Fig. 3:

Molecular structure and atom labeling scheme of (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8h, top). The ellipsoids represent a probability of 30%, hydrogen atoms are shown with arbitrary radii. At the bottom, aggregation via hydrogen bonds (dotted lines) is shown. Only the non-hydrogen atoms are drawn with arbitrary radii.

Fig. 4: Molecular structure and atom labeling scheme of (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8i, top). The ellipsoids represent a probability of 30%, hydrogen atoms are shown with arbitrary radii. At the bottom, dimerization via hydrogen bonds (dotted lines) is depicted. All atoms are shown with arbitrary radii for clarity reasons.
Fig. 4:

Molecular structure and atom labeling scheme of (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8i, top). The ellipsoids represent a probability of 30%, hydrogen atoms are shown with arbitrary radii. At the bottom, dimerization via hydrogen bonds (dotted lines) is depicted. All atoms are shown with arbitrary radii for clarity reasons.

Selected bond lengths of BOX A (8a) [11], 8h (molecules A and B), and 8i are compared in Table 4. The structural parameters of the pyrrole ring are very similar and the transformation of the ester functionality into an amide does not affect the endocyclic N–C and C–C bond lengths. The exocyclic aryl groups at C3 are orientated nearly perpendicular to the pyrrole ring prohibiting significant interactions between these π systems. Hence, typical C3–C31 single bonds are observed which are comparable to the C4–C41 bond lengths to the methyl substituents. The amide functionality shows a slight charge delocalization within the O23–C22–N23 unit, leading to larger C22–O23 bond lengths compared to C5–O51 and shorter C22–N23 bonds in comparison to the endocyclic N1–C2/5 bond lengths.

Table 4:

Selected bond lengths (pm) of 3-aryl- and 3-alkenyl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetamides (numbering of pyrrol atoms according to IUPAC recommendation, exo-positioned atoms are numbered with a second digit).

8a (BOX A)8h (molecule A)8h (molecule B)8i
N1–C2138.8(3)138.80(17)139.17(17)138.4(3)
C2–C3147.7(3)148.28(18)148.37(18)147.7(3)
C3=C4135.2(3)134.59(19)135.26(19)134.5(4)
C4–C5148.8(3)149.51(18)148.77(19)149.9(3)
N1–C5136.9(3)137.43(18)136.73(18)137.9(3)
C2=C21exo133.9(3)134.32(19)134.77(19)134.4(4)
C21–C22amide147.6(3)147.84(18)147.61(18)147.7(3)
C22amide–O23124.9(3)124.92(17)124.63(17)124.3(3)
C22amide–N23133.6(3)133.88(18)133.37(18)134.2(4)
C3–C31exo147.0(3)149.09(18)148.02(18)149.0(3)
C4–C41Me148.8(3)149.34(19)148.72(19)148.5(4)
C5=O51122.3(2)122.72(17)122.57(17)121.6(3)
Ref.[11]This workThis workThis work

Compound 8h forms an extended hydrogen bonding network via intermolecular N1A–H1A⋯O23B (146.1(18)°, N1A⋯O23B 273.72(15) pm) and N1B–H1B⋯O51A (155.8(18)°, N1B⋯O51A 305.68(16) pm) bridges. In addition, the methanol molecule is connected to the amide functionalities (N23A–H23A⋯O1M and O1M–H1M⋯O23B). The other amide N23A–H23B coordinates to the amide carbonyl group of the neighboring molecule. This extended hydrogen bonding network significantly reduces the solubility of 8h in common organic solvents. In contrast to this aggregation, compound 8i with the bulkier 3,5-bis(trifluoromethyl)phenyl groups only forms dimers in the crystalline state but of a different nature than observed for the derivative 5. Dimerization occurs via intermolecular hydrogen bonds between the amide functionalities (N23–H23A⋯O23′ 178(4)°, N23⋯O23′ 293.8(3) pm) whereas the N1–H1 fragment shows no short contacts to Lewis basic sites of neighboring molecules.

2.4 NMR spectroscopy

The 13C{1H} NMR chemical shifts of the pyrrole units of 3-aryl- and 3-alkenyl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates 5 as well as methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetamides 8 are listed in Table 5. The atom numbering is in accordance with the IUPAC nomenclature and identical to the molecule representations in Figs. 24. Furthermore, the δ values of the groups at C2 and C4 are included in this table. The solubility of the methyl acetates 5 in common organic solvents is significantly higher than the solubility of the acetamides 8. Therefore the latter compounds had to be dissolved in DMSO-d6 in order to break down the hydrogen bonding network and to obtain reliable and meaningful 13C{1H} NMR spectra.

Table 5:

13C{1H} chemical shifts (ppm) of the pyrrole units of 3-alkenyl- (entries 1–3 and 12) and 3-aryl-substituted (entries 4–11 as well as 13 and 14) methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates 5 as well as methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetamides 8 (numbering of pyrrole atoms according to IUPAC recommendation, exo-positioned atoms are numbered with a second digit; see Figs. 24).

EntryComp.SolventC2C3C4C5C21C22C41Ref.
15aDMSO-d6149.0138.5131.1171.194.3166.39.6[11]
25bDMSO-d6149.5139.7129.1171.593.9166.49.6This work
35cDMSO-d6148.9146.0130.8171.194.9166.19.0This work
45dDMSO-d6149.6143.8132.2171.195.9165.99.2This work
55eDMSO-d6149.7144.0132.0171.195.9166.09.2This work
65fDMSO-d6149.7143.9131.8171.195.8166.09.1This work
75gDMSO-d6151.6143.8131.8171.295.9165.99.2This work
85hCDCl3150.0142.8134.6170.796.5167.69.6This work
95iCDCl3149.5141.1136.0170.196.5167.49.7This work
105jDMSO-d6149.6143.9132.7171.196.2166.09.6This work
115kDMSO-d6147.3145.1130.1170.696.5166.010.0This work
128aDMSO-d6145.7139.1130.8170.398.5168.09.3[11]
138hDMSO-d6146.0142.1132.7170.0100.3167.79.1This work
148iDMSO-d6146.0140.7134.0169.7100.2167.69.1This work

The 13C{1H} NMR shifts of the pyrrole carbon atoms C2 and C5, which bind to N1, vary within very narrow ranges around 171 and 149 ppm, respectively. The C3 atoms are bound to alkenyl and aryl groups and the influence of these substituents on the chemical shifts are also very small. In addition, the nature of the functional group of C22 (ester for entries 1–11, compound 5; amide for entries 12–14, derivative 8) shows a negligible influence on the chemical shift of this carbon atom. In agreement with the negligible influence of the substituents at C3 on the chemical shifts of the carbon atoms of the pyrrole ring, also the δ(13C{1H}) values of the C4-bound methyl group C41 vary only within a very narrow range of 9.5±0.5 ppm. However, the methyl resonances are high field-shifted compared to simple compounds with methyl groups bound to alkene moieties as in propene (δ(CH3)=19.4 ppm), (Z)-2-butene (δ(CH3)=11.4 ppm), (E)-2-butene (δ(CH3)=16.8 ppm), (Z)-penta-1,3-diene (δ(CH3)=12.8 ppm), and (E)-penta-1,3-diene (δ(CH3)=17.2 ppm) [25].

3 Conclusion

During the synthesis of methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) we observed the intermediate hydration product 2 which we were able to prepare with a yield of 78%. Isolation and characterization of this intermediately formed methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2) verifies that the ammonia molecule attacks the ring at the carbonyl group rather than at the alkylidene fragment. At higher reaction temperatures the water molecule is eliminated and the pyrrole derivative 3 is formed. Isolation of 2 prior to the conversion to 3 is not needed but higher reaction temperatures are recommended in order to avoid the formation and isolation of mixtures of 2 and 3.

The Suzuki-Miyaura cross-coupling sequence allows to form C–C bonds between sp2-hybridized carbon atoms leading to alkenyl- and aryl-substituted pyrroles. Thus the palladium-mediated reaction of methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) with potassium aryl- or alkenyl-trifluoroborate (4) yields 3-alkenyl- or 3-aryl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (5). Generally the yields of isolated products are above 80% making this protocol a powerful procedure to exchange the bromine atom of the pyrroles 3 by alkenyl- and aryl-groups in 3-position. The influence of this substituent on structural and NMR spectroscopic parameters of the pyrrolylidene fragment is negligible. Furthermore, these groups do not hamper the conversion to the amides 8 as we could demonstrate for the synthesis of (Z)-2-(4-methyl-5-oxo-3-(4-trifluoromethylphenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8h) and (Z)-2-(4-methyl-5-oxo-3-(3,5-bis(trifluoromethyl)phenyl)-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (8i) in analogy to the preparation of biologically highly active (Z)-2-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)acetamide (BOX A, 8a).

Contrary to the structural and NMR parameters that remain nearly unaffected by the substituents in 3-position, solubility of the acetamides 8 and methyl acetates 5 are strikingly different due to the formation of hydrogen bonding networks. The esters 5 form dimers in the solid state and are quite soluble in common organic solvents whereas the acetamide 8h with a 4-trifluoromethylphenyl substituent is only very sparingly soluble due to fact that the amide group is involved in extended hydrogen bonding networks. Contrary to the molecular parameters like bond lengths and chemical NMR shifts, aggregation of 8 via hydrogen bonds in the solid state is highly influenced by the substituents at C31 and hence, 8i with the bulkier 3,5-bis(trifluoromethyl)phenyl group only forms dimers via intermolecular hydrogen bonds between the amide functionalities. Increasingly bulky groups reduce the degree of aggregation, enhancing solubility in common organic solvents.

This derivatization via the Suzuki-Miyaura cross-coupling reaction allows to introduce 19F labeled groups to follow mode of action and fate of these BOX A-type monopyrrolic heterocycles by 19F NMR spectroscopy. Future in vivo studies must show to what extent these substituents in 3-position of the pyrrole ring influence and alter the biological activity due to their increasingly bulky groups (e.g. for key-lock-type interactions) and their different ability and degree to form intermolecular hydrogen bonding networks.

4 Experimental section

The substrates methyl (Z)-2-(3-bromo-4-methyl-5-oxofuran-2(5H)-ylidene)acetate (1) and methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) were prepared according to literature protocols [6]. 1H, 13C and 19F NMR spectra were recorded on Bruker AC250, AC400 and AC600 spectrometers using the residual solvent resonances (1H and 13C NMR) as internal standards. Chemical shifts (δ) are reported in ppm. CDCl3 (δ(1H)=7.26, δ(13C)=77.2), CD2Cl2 (δ(1H)=5.32, δ(13C)=53.8), and DMSO-d6 (δ(1H)=2.49, δ(13C)=39.5) were used as solvents for NMR experiments [26]. IR bands (ν) are reported in cm−1. Mass spectrometric experiments were performed on Finnigan MAT SSQ 710 and ThermoFinnigan MAT 95 XL instruments. Elemental analyses were provided by the Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, using a Leco CHNS-932 Elemental Analyzer. Merck silica gel 60 (0.040–0.063 mm) was used for column chromatography. Physical data and molecular structures of the compounds 5b5g as well as 5j and 5k are supplied in the Supporting Information available online.

4.1 Methyl 2-(3-bromo-2-hydroxy-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)acetate (2)

Method A: A solution of methyl (Z)-2-(3-bromo-4-methyl-5-oxofuran-2(5H)-ylidene)acetate (1) (150 mg, 0.61 mmol), ammonium acetate (234 mg, 3.04 mmol) and acetic anhydride (1 drop) in glacial acetic acid (4 mL) was stirred at 70°C for 5 h. After cooling to r. t., the solvent was evaporated to dryness and the solid residue taken up in 30 mL of ethyl acetate. The solution was washed with water (2×10 mL) and brine (10 mL) and the combined aqueous layers were extracted once with ethyl acetate (10 mL). The combined organic layers were dried over anhydrous Na2SO4 and the solvent removed in vacuo. The residue was transferred into a frit, washed with a small amount of dichloromethane and dried in vacuo to provide 2 as a colorless solid (yield: 125 mg, 78%).

Method B: An aqueous ammonia solution (1 mL, 25%) was added to a solution of methyl (Z)-2-(3-bromo-4-methyl-5-oxofuran-2(5H)-ylidene)acetate (1) (230 mg, 0.93 mmol) in 10 mL of methanol. After stirring at r. t. for 1 h the solvent was removed in vacuo and the remaining orange solid was taken up in water (10 mL) and extracted with ethyl acetate (3×15 mL). The combined organic layers were dried over anhydrous Na2SO4 and the solvents removed in vacuo, yielding a pale yellow solid which was recrystallized from ethyl acetate to provide colorless needles of 2. The crystals were collected, washed with a small amount of ethyl acetate and dried in vacuo (yield: 72 mg, 29%).

Physical data of 2: 1H NMR (400 MHz, CDCl3, 297 K): δ=7.03 (s, 1H, NH), 3.78 (s, 3H, COOCH3), 3.43 (s, 1H, OH), 3.17 (d, J=16.2 Hz, 1H, CHAHB), 2.50 (d, J=16.2 Hz, 1H, CHAHB), 1.88 (s, 3H, CH3). – 1H NMR (400 MHz, DMSO-d6, 297 K): δ=8.68 (s, 1H, NH), 6.45 (s, 1H, OH), 3.54 (s, 3H, COOCH3), 2.80 (d, J=15.0 Hz, 1H, CHAHB), 2.76 (d, J=15.0 Hz, 1H, CHAHB), 1.70 (s, 3H, CH3). – 13C{1H} NMR (101 MHz, DMSO-d6, 297 K): δ=168.70 (CONH), 168.29 (COOCH3), 139.65 (C–Br), 132.97 (C–CH3), 85.82 (C–OH), 51.39 (COOCH3), 41.30 (CH2), 9.87 (CH3). – MS (DEI): m/z (%)=265 (22) [M(81Br)]+, 263 (20) [M(79Br)]+, 248 (37), 246 (36), 234 (50), 232 (52), 216 (11), 214 (13), 192 (87), 190 (94), 184 (100), 174 (27), 172 (25). – Elemental analysis (C8H10BrNO4, 264.08): calcd.: C 36.39, H 3.82, N 5.30; found C 36.33, H 3.70, N 5.43.

4.2 General procedure for 3-aryl- and 3-alkenyl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates (5b–5k)

A solution of 246 mg of methyl (Z)-2-(3-bromo-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetate (3) (1 mmol), the corresponding potassium aryl- or alkenyl-trifluoroborate (4b4k, 1.5 mmol, 1.5 equiv.), 35.1 mg of Pd(PPh3)2Cl2 (0.05 mmol, 5 mol-%) and 456 mg of CsF (3 mmol, 3 equiv.) in 10 mL of a degassed mixture of tetrahydrofuran and water (ratio 4:1) was heated under reflux for 18 h in a nitrogen atmosphere. After complete conversion and cooling to r. t. 50 mL of diethyl ether was added. The organic layer was separated, washed twice with 25 mL of water and three times with 25 mL of brine. The organic phase was dried over anhydrous sodium sulfate. Then the volatiles were removed in vacuo and a subsequent chromatographic purification (silica gel, petroleum ether-ethyl acetate 1:1) gave analytically pure products 5b5k.

Physical data of 5h: Yield: 238 mg (0.76 mmol, 94%), colorless solid. – 1H NMR (400.21 MHz, CDCl3, 297 K): δ=9.30 (s, br, 1H, NH), 7.75 (d, 3JH,H=8.2 Hz, 2H, m-CHpCF3Ph), 7.42 (d, 3JH,H=8.1 Hz, 2H, o-CHpCF3Ph), 5.21 (s, 1H, CH), 3.76 (s, 3H, COOCH3), 2.01 (s, 3H, CH3). – 13C{1H} NMR (100.61 MHz, CDCl3, 297 K): δ=170.7 (CONH), 167.6 (COOCH3), 150.0 (C=CH), 142.8 (C−C6H4CF3), 134.6 (C−CH3), 134.1 (d, 5JC,F=1.3 Hz, ipso-CpCF3Ph), 131.4 (q, 2JC,F=32.8 Hz, C−CF3), 129.7 (s, o-CHpCF3Ph), 125.9 (q, 3JC,F=3.7 Hz, m-CHpCF3Ph), 123.9 (q, 1JC,F=272.5 Hz, CF3), 96.5 (C=CH), 52.0 (COOCH3), 9.6 (CH3). – 19F NMR (376.58 MHz, CDCl3, 297 K): δ=−62.84 (s, CF3). – IR (ATR): 3247 (m, br), 3082 (m), 3001 (m), 2952 (m), 1687 (s), 1625 (m), 1428 (m), 1408 (m), 1380 (m), 1357 (m), 1319 (s), 1266 (m), 1173 (s), 1106 (s), 1064 (s), 1048 (s), 1014 (s), 991 (m), 957 (m), 876 (m), 862 (m), 845 (s), 765 (s), 747 (m), 733 (m), 704 (m), 694 (s), 634 (m), 612 (m), 586 (m), 535 (m), 493 (m), 437 (m), 421 (m). – MS (DEI): m/z (%)=311 (100) [M]+, 283 (56) [M–CO]+, 280(34) [M–CH3O]+, 251(32) [M–CH3OH–CO]+, 223 (41) [M–CH3OH–2CO]+, 154 (18) [C11H8N]+, 115 (11) [C9H7]+. – Elemental analysis (C15H12F3NO3, 311.26): calcd.: C 57.88, H 3.89, N 4.50; found C 57.81, H 3.96, N 4.47.

Physical data of 5i: Yield: 227 mg (0.60 mmol, 98%), colorless solid. – 1H NMR (400.21 MHz, CDCl3, 297 K): δ=9.38 (s, 1H, NH), 7.99 (s, 1H, p-CHm(CF3)2Ph), 7.75 (s, 2H, o-CHm(CF3)2Ph), 5.14 (s, 1H, CH), 3.78 (s, 3H, COOCH3), 2.02 (s, 3H, CH3). – 13C{1H} NMR (100.63 MHz, CDCl3, 297 K): δ=170.1 (CONH), 167.4 (COOCH3), 149.5 (C=CH), 141.1 (C−C6H3(CF3)2), 136.0 (C−CH3), 132.7 (ipso-Cm(CF3)2Ph), 132.7 (q, 2JC,F=33.9 Hz, C−CF3), 129.4 (d, 3JC,F=3.1 Hz, o-CHm(CF3)2Ph), 123.2 (q, 3JC,F=3.8 Hz, p-CHm(CF3)2Ph), 123.0 (q, 1JC,F=272.8 Hz, CF3), 96.5 (C=CH), 52.1 (COOCH3), 9.7 (CH3). – 19F NMR (376.58 MHz, CDCl3, 297 K): δ=−62.90 (s, CF3). – IR (ATR): 3404 (m), 3060 (w), 2957 (w), 1720 (s), 1691 (s), 1665 (m), 1638 (s), 1444 (m), 1411 (m), 1396 (m), 1380 (m), 1321 (m), 1281 (s), 1261 (s), 1206 (m), 1176 (s), 1158 (s), 1111 (s), 1049 (m), 1033 (m), 1000 (m), 955 (m), 934 (m), 913 (s), 873 (m), 848 (m), 831 (s), 759 (m), 712 (m), 681 (s), 650 (m), 627 (m), 600 (s), 493 (m), 447 (m), 417 (m). – MS (DEI): m/z (%)=379 (100) [M]+, 351 (47) [M–CO]+, 348 (99) [M–CH3O]+, 319 (23) [M–CH3OH–CO]+, 291 (36) [M–CH3OH–2CO]+. – Elemental analysis (C16H11F6NO3, 379.26): calcd.: C 50.67, H 2.92, N 3.69; found C 50.54, H 3.06, N 3.38.

4.3 General procedure for 3-(4-(trifluoromethyl)phenyl)- and 3-(3,5-bis(trifluoromethyl)phenyl)-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetic acids (6h and 6i)

Solutions of the methyl esters 5h and 5k in THF (3.9–4.7 mL mmol−1) were reacted with 3 equiv. of an aqueous 2 m LiOH solution at 0°C and then at r. t. for additional 25–27 h. Diluted hydrochloric acid was added till a pH value of 2 was realized. Then 20 mL of ethyl acetate was added and the remaining aqueous phase extracted three times with 10 mL of ethyl acetate. The combined organic phases were washed with 10 mL of a saturated NaCl solution and dried over anhydrous Na2SO4. After filtration, the solvent of the filtrate was removed in vacuo. Purity was checked by NMR spectroscopy and the acids 6h and 6i were used for transformations without further purification.

Physical data of 6h: Yield: 175 mg (0.59 mmol, 92%). – 1H NMR (400.13 MHz, DMSO-d6, 296 K): δ=12.68 (s, br, 1H, COOH), 10.04 (s, 1H, NH), 7.89 (d, 3JH,H=8.1 Hz, 2H, m-CHpCF3Ph), 7.62 (d, 3JH,H=8.0 Hz, 2H, o-CHpCF3Ph), 5.03 (s, 1H, CH), 1.88 (s, 3H, CH3). – 13C{1H} NMR (100.61 MHz, DMSO-d6, 296 K): δ=170.5 (CONH), 167.2 (COOH), 148.9 (C=CH), 142.3 (C−C6H4CF3), 134.5 (d, 5JC,F=1.4 Hz, ipso-CpCF3Ph), 133.5 (C−CH3), 130.2 (s, o-CHpCF3Ph), 129.3 (q, 2JC,F=32.0 Hz, C−CF3), 125.7 (q, 3JC,F=3.7 Hz, m-CHpCF3Ph), 124.1 (q, 1JC,F=272.3 Hz, CF3), 97.4 (C=CH), 9.2 (CH3). – 19F NMR (376.58 MHz, DMSO-d6, 297 K): δ=−61.21 (s, CF3). – IR (ATR): 3416 (w), 3268 (w), 3219–2231 (m, br), 2929 (m), 1726 (m), 1707 (m), 1676 (m), 1643 (m), 1618 (m), 1450 (m), 1409 (m), 1382 (w), 1356 (m), 1322 (s), 1296 (m), 1253 (m), 1229 (m), 1206 (m), 1167 (m), 1110 (s), 1067 (m), 1018 (m), 995 (m), 948 (m), 842 (m), 776 (m), 761 (m), 743 (m), 695 (m), 670 (m), 635 (m), 617 (m), 578 (m), 535 (m), 491 (m), 458 (m), 441 (m). – MS (DEI): m/z (%)=297 (100) [M]+, 280 (11) [M–OH]+, 269 (36) [M–CO]+, 251 (22) [M–H2O–CO]+, 225 (60) [M+H–COOH–CO]+, 154 (28) [C11H8N]+, 115 (21) [C9H7]+. – Elemental analysis (C14H10F3NO3, 297.23): calcd.: C 56.57, H 3.39, N 4.71; found C 56.68, H 3.83, N 4.27.

Physical data of 6i: Yield: 192 mg (0.53 mmol, 99%), pale yellow solid. – 1H NMR (400.21 MHz, DMSO-d6, 297 K): δ=12.70 (s, br, 1H, COOH), 10.10 (s, 1H, NH), 8.24 (s, 1H, p-CHm(CF3)2Ph), 8.12 (s, 2H, o-CHm(CF3)2Ph), 4.97 (s, 1H, CH), 1.87 (s, 3H, CH3). – 13C{1H} NMR (100.63 MHz, DMSO-d6, 297 K): δ=170.2 (CONH), 167.1 (COOH), 148.7 (C=CH), 140.9 (C−C6H3(CF3)2), 134.7 (C−CH3), 133.0 (ipso-Cm(CF3)2Ph), 130.8 (q, 2JC,F=33.2 Hz, C−CF3), 130.2 (d, 3JC,F=3.1 Hz, o-CHm(CF3)2Ph), 123.1 (q, 1JC,F=273.1 Hz, CF3), 122.8 (q, 3JC,F=3.6 Hz, p-CHm(CF3)2Ph), 97.5 (C=CH), 9.2 (CH3). – 19F NMR (376.58 MHz, DMSO-d6, 297 K): δ=−61.20 (s, CF3). – IR (ATR): 3271 (w), 3215–2285 (w, br), 2927 (w), 1706 (m), 1679 (m), 1651 (m), 1468 (m), 1439 (m), 1404 (m), 1379 (m), 1322 (m), 1276 (s), 1213 (m), 1167 (s), 1124 (s), 1032 (m), 903 (m), 885 (m), 847 (m), 832 (m), 760 (m), 706 (m), 681 (s), 644 (m), 628 (m), 576 (m), 509 (m), 443 (m), 417 (m). – MS (DEI): m/z (%)=365 (100) [M]+, 348 (22) [M–OH]+, 337 (29) [M–CO]+, 319 (22) [M–H2O–CO]+, 293 (72) [M+H–COOH–CO]+. – Elemental analysis (C15H9F6NO3, 365.23): calcd.: C 49.33, H 2.48, N 3.84; found C 49.83, H 3.07, N 3.38.

4.4 General procedure for 3-(4-trifluoromethylphenyl)- and 3-(3,5-bis(trifluoromethyl)phenyl)-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetyl chlorides (7h and 7i)

A drop of DMF and 1.3 equivalents of DCM were added at r. t. to a solution of the acetic acids 6h and 6i. After stirring for 2 h and ceased gas evolution the volatiles were removed in vacuo. The remaining solid was dried in vacuo and these products 7h and 7i were used for the final conversion without further purification.

Physical data of 7h: Yield: 170 mg (0.54 mmol, 95%), light brown solid. – 1H NMR (400.13 MHz, [D8]THF, 297 K): δ=10.24 (s, br, 1H, NH), 7.85 (d, 3JH,H=8.2 Hz, 2H, m-CHpCF3Ph), 7.58 (d, 3JH,H=8.1 Hz, 2H, o-CHpCF3Ph), 5.40 (s, 1H, CH), 1.95 (s, 3H, CH3). – 13C{1H} NMR (100.61 MHz, [D8]THF, 297 K): δ=171.8 (CONH), 164.4 (COCl), 153.8 (CCH), 143.8 (C−C6H4CF3), 136.8 (C−CH3), 135.0 (ipso-CpCF3Ph), 131.9 (q, 2JC,F=32.4 Hz, C−CF3), 130.9 (s, o-CHpCF3Ph), 126.7 (q, 3JC,F=3.8 Hz, m-CHpCF3Ph), 125.1 (q, 1JC,F=272.2 Hz, CF3), 100.4 (C=CH), 9.4 (CH3). – 19F NMR (376.58 MHz, [D8]THF, 297 K): δ=−63.60 (s, CF3). – MS (DEI): m/z (%)=315 (41) [M]+, 280 (100) [M–Cl]+.– HRMS (EI): m/z=315.0279 (calcd. 315.0274 for C14H9ClF3NO2, [M]+.

Physical data for 7i: Yield: 160 mg (0.42 mmol, 99%), brown solid. – 1H NMR (400.13 MHz, [D8]THF, 297 K): δ=10.34 (s, br, 1H, NH), 8.19 (s, 1H, p-CHm(CF3)2Ph), 8.02 (s, 2H, o-CHm(CF3)2Ph), 5.37 (s, 1H, CH), 1.94 (s, 3H, CH3). – 13C{1H} NMR (100.61 MHz, [D8]THF, 297 K): δ=171.5 (CONH), 164.4 (COCl), 153.4 (CCH), 142.5 (C−C6H3(CF3)2), 138.0 (C−CH3), 133.7 (ipso-Cm(CF3)2Ph), 133.0 (q, 2JC,F=33.5 Hz, C−CF3), 130.8 (q, 3JC,F=3.9 Hz, o-CHm(CF3)2Ph), 124.3 (q, 1JC,F=272.7 Hz, CF3), 124.1 (q, 3JC,F=3.6 Hz, p-CHm(CF3)2Ph), 100.6 (C=CH), 9.4 (CH3). – 19F NMR (376.58 MHz, [D8]THF, 297 K): δ=−65.52 (s, CF)3. – MS (DEI): m/z (%)=383 (19) [M]+, 348 (100) [M–Cl]+.

4.5 General procedure for 3-(4-trifluoromethylphenyl)- and 3-(3,5-bis(trifluoromethyl)phenyl)-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetamides (8h and 8i)

Ammonia was passed into a solution of the acetyl chlorides 7h and 7i in anhydrous THF at 0°C. After 30 min the cooling bath was removed and ammonia was passed into this reaction mixture for approximately an additional hour. During this time the clouding of the solution intensified. Thereafter the solvent was removed in vacuo and the residue was purified as given below.

Purification and physical data for 8h: The residue was washed four times with 3 mL of water and dried in vacuo. Recrystallization from methanol yielded yellow crystals of 8h·0.55MeOH. Yield: 106 mg (0.34 mmol, 67%). Methanol-free samples were obtained by dissolution of 8h·0.55MeOH in acetone and distillation to remove MeOH. The residue was suspended in diethyl ether and the solvent removed in vacuo. Thereafter, the colorless residue was thoroughly dried in vacuo. – 1H NMR (400.13 MHz, DMSO-d6, 297 K): δ=10.09 (s, 1H, NH), 7.91 (d, 3JH,H=8.1 Hz, 2H, m-CHpCF3Ph), 7.68 (s, 1H, NH2), 7.63 (d, 3JH,H=8.0 Hz, 2H, o-CHpCF3Ph), 7.27 (s, 1H, NH2), 5.36 (s, 1H, CH), 1.88 (s, 3H, CH3). – 13C{1H} NMR (100.61 MHz, DMSO-d6, 297 K): δ=170.0 (CONH), 167.7 (CONH2), 146.0 (C=CH), 142.1 (C−C6H4CF3), 134.9 (d, 5JC,F=1.2 Hz, ipso-CpCF3Ph), 132.7 (C−CH3), 130,2 (s, o-CHpCF3Ph), 129.2 (q, 2JC,F=31.9 Hz, C−CF3), 125.7 (q, 3JC,F=3.7 Hz, m-CHpCF3Ph), 124.1 (q, 1JC,F=272.3 Hz, CF3), 100.3 (C=CH), 9.1 (CH3). – 19F NMR (376.58 MHz, DMSO-d6, 297 K): δ=−61.21 (s, CF3). – IR (ATR): 3359 (m), 3151 (m), 2920 (w), 2790 (w), 1703 (s), 1665 (s), 1649 (s), 1609 (s), 1434 (m), 1410 (m), 1388 (m), 1360 (m), 1321 (s), 1299 (s), 1262 (m), 1175 (s), 1137 (s), 1112 (s), 1066 (s), 1042 (m), 1021 (m), 997 (m), 959 (m), 933 (m), 854 (m), 838 (s), 760 (m), 743 (m), 722 (m), 706 (m), 695 (m), 647 (s), 609 (s), 586 (s), 533 (m), 491 (m), 444 (m), 419 (m). – MS (DEI): m/z (%)=296 (100) [M]+, 280 (23) [M–NH2]+, 268 (22) [M–CO]+, 251 (58) [M–NH3–CO]+, 225 (94) [M+H–CONH2–CO]+, 154 (18) [C11H8N]+, 115 (21) [C9H7]+. – Elemental analysis (C14H11F3N2O2, 296.25): calcd.: C 56.76, H 3.74, N 9.46; found C 56.31, H 3.94, N 9.13.

Purification and physical data for 8i: The product was washed with water (4×3 mL) and dried in vacuo. The solid residue was dissolved in methanol and at 4°C an amorphous solid precipitated, which was collected, washed with a few milliliters of methanol and dried in vacuo. Yield: 68 mg (0.19 mmol, 53%), colorless solid. Single crystals were obtained by evaporation of the solvent from the methanol mother liquor. – 1H NMR (400.13 MHz, DMSO-d6, 297 K): δ=10.14 (s, 1H, NH), 8.27 (s, 1H, p-CHm(CF3)2Ph), 8.12 (s, 2H, o-CHm(CF3)2Ph), 7.69 (s, 1H, NH2), 7.28 (s, 1H, NH2), 5.25 (s, 1H, CH), 1.86 (s, 3H, CH3). – 13C{1H} NMR (100.63 MHz, DMSO-d6, 297 K): δ=169.7 (CONH), 167.6 (CONH2), 146.0 (C=CH), 140.7 (C−C6H3(CF3)2), 134.0 (C−CH3), 133.4 (ipso-Cm(CF3)2Ph), 130.8 (q, 2JC,F=33.2 Hz, C−CF3), 130.2 (d, 3JC,F=2.5 Hz, o-CHm(CF3)2Ph), 123.1 (q, 1JC,F=273.0 Hz, CF3), 122.8 (q, 3JC,F=3.8 Hz, p-CHm(CF3)2Ph), 100.2 (C=CH), 9.1 (CH3). – 19F NMR (376.58 MHz, DMSO-d6, 297 K): δ=−61.15 (s, CF3). – IR (ATR): 3500 (m), 3417 (m), 3311 (w), 3257 (w), 3168 (m), 3066 (m), 1722 (m), 1679 (m), 1638 (m), 1600 (m), 1470 (m), 1437 (m), 1406 (m), 1376 (m), 1353 (m), 1322 (m), 1280 (s), 1238 (m), 1170 (s), 1122 (s), 1030 (m), 917 (m), 870 (m), 848 (m), 827 (m), 779 (m), 763 (m), 712 (m), 706 (m), 680 (m), 666 (m), 630 (m), 616 (m), 593 (s), 533 (m), 508 (m), 479 (s), 441 (m), 419 (m). – MS (DEI): m/z (%)=364 (88) [M]+, 348 (83) [M–NH2]+, 336 (9) [M–CO]+, 319 (83) [M–NH3–CO]+, 293 (100) [M+H–CONH2–CO]+. – Elemental analysis (C15H10F6N2O2, 364.25): calcd.: C 49.46, H 2.77, N 7.69; found C 49.79, H 3.43, N 7.33.

4.6 X-ray structure determinations

The intensity data for the compounds was collected on a Nonius KappaCCD diffractometer using graphite-monochromatized Mo radiation. Data was corrected for Lorentz and polarization effects; absorption was taken into account on a semi-empirical basis using multiple-scans [27], [28], [29]. The structures were solved by direct methods (Shelxs) [30] and refined by full-matrix least squares techniques against Fo2 (Shelxl-97) [31]. The hydrogen atoms bonded to the amine groups N1A–N1D of 5f and all other hydrogen atoms (with exception of the methyl groups C33A and C41B of 5c) were located by difference Fourier synthesis and refined isotropically. The remaining hydrogen atoms of 5f were included at calculated positions with fixed thermal parameters. All non-hydrogen atoms were refined anisotropically [31]. Crystallographic data as well as structure solution and refinement details are summarized in Table S2 (see Supporting Information). XP [32] and POV-Ray [33] were used for structure representations.

Crystallographic data (excluding structure factors) has been deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC 1945677 for 2, CCDC 1945678 for 5b, CCDC 1945679 for 5c, CCDC 1945680 for 5d, CCDC 1945681 for 5e, CCDC 1945682 for 5f, CCDC 1945683 for 5g, CCDC 1945684 for 5h, CCDC 1945685 for 5j, CCDC 1945686 for 8h, and CCDC 1945687 for 8i. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre viawww.ccdc.cam.ac.uk/data_request/cif.

5 Supporting information

Preparative details and characterization of 3-alkenyl- and 3-aryl-substituted methyl (Z)-2-(4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)acetates, crystal data and refinement details of the X-ray structure determinations, and additional representations of the molecular structures are given as Supplementary Material available online (DOI: 10.1515/znb-2019-0125).


Dedicated to: Professor Arndt Simon on the occasion of his 80th birthday.


Acknowledgment

This work was financially supported by the Researcher Group FOR 1738 (German Research Foundation, DFG, Bonn/Germany); for more details see also the homepage at http://www.hhdp.uni-jena.de. D. S. is grateful to the Graduate Academy of the Friedrich Schiller University Jena for a finalization stipend for the dissertation. We also acknowledge the valuable support of the NMR service platform (www.nmr.uni-jena.de) and of the mass spectrometry platform (www.ms.uni-jena.de) of the Faculty of Chemistry and Earth Sciences of the Friedrich Schiller University Jena, Germany.

References

[1] D. A. Lightner, G. B. Quistad, FEBS Lett.1972, 25, 94–96.10.1016/0014-5793(72)80462-9Suche in Google Scholar

[2] R. Bonnett, J. C. M. Stewart, J. Chem. Soc. Chem. Commun.1972, 596–597.10.1039/c39720000596Suche in Google Scholar

[3] R. Bonnett, J. C. M. Stewart, J. Chem. Soc. Perkin Trans. I1975, 224–231.10.1039/p19750000224Suche in Google Scholar

[4] W. H. Schaefer, T. M. Harris, F. P. Guengerich, Biochemistry1985, 24, 3254–3263.10.1021/bi00334a027Suche in Google Scholar PubMed

[5] M. Ritter, R. A. Seidel, P. Bellstedt, B. Schneider, M. Bauer, H. Görls, G. Pohnert, Org. Lett.2016, 18, 4432–4435.10.1021/acs.orglett.6b02287Suche in Google Scholar PubMed

[6] R. A. Seidel, M. Kahnes, M. Bauer, G. Pohnert, J. Chromatogr. B2015, 974, 83–89.10.1016/j.jchromb.2014.10.027Suche in Google Scholar PubMed

[7] R. A. Seidel, T. Claudel, F. A. Schleser, N. K. Ojha, M. Westerhausen, S. Nietzsche, C. Sponholz, F. Cuperus, S. M. Coldewey, S. H. Heinemann, G. Pohnert, M. Trauner, M. Bauer, J. Hepatol.2017, 67, 272–281.10.1016/j.jhep.2017.03.037Suche in Google Scholar PubMed

[8] R. L. Macdonald, R. M. Pluta, J. H. Zhang, Nat. Clin. Pract. Neurol.2007, 3, 256–263.10.1038/ncpneuro0490Suche in Google Scholar PubMed

[9] K. R. Kranc, G. J. Pyne, L. Tao, T. D. W. Claridge, D. A. Harris, T. A. D. Cadoux-Hudson, J. J. Turnbull, C. J. Schofield, J. F. Clark, Eur. J. Biochem.2000, 267, 7094–7101.10.1046/j.1432-1327.2000.01812.xSuche in Google Scholar PubMed

[10] M. Ritter, S. Neupane, R. A. Seidel, C. Steinbeck, G. Pohnert, Org. Biomol. Chem.2018, 16, 3553–3555.10.1039/C8OB00164BSuche in Google Scholar

[11] M. Klopfleisch, R. A. Seidel, H. Görls, H. Richter, R. Beckert, W. Imhof, M. Reiher, G. Pohnert, M. Westerhausen, Org. Lett.2013, 15, 4608–4611.10.1021/ol402221bSuche in Google Scholar

[12] R. A. Seidel, B. Schowtka, M. Klopfleisch, T. Kühl, A. Weiland, A. Koch, H. Görls, D. Imhof, G. Pohnert, M. Westerhausen, Tetrahedron Lett.2014, 55, 6526–6529.10.1016/j.tetlet.2014.09.108Suche in Google Scholar

[13] D. Schulze, J. Traber, M. Ritter, H. Görls, G. Pohnert, M. Westerhausen, Org. Biomol. Chem.2019, 17, 6489–6496.10.1039/C9OB01117JSuche in Google Scholar

[14] S. Hou, R. Xu, J. F. Clark, W. L. Wurster, S. H. Heinemann, T. Hoshi, J. Cereb. Blood Flow Metabol.2011, 31, 102–112.10.1038/jcbfm.2010.54Suche in Google Scholar

[15] A. Joerk, R. A. Seidel, S. G. Walter, A. Wiegand, M. Kahnes, M. Klopfleisch, K. Kirmse, G. Pohnert, M. Westerhausen, O. W. Witte, K. Holthoff, J. Am. Heart Assoc.2014, 3, e001220.10.1161/JAHA.114.001220Suche in Google Scholar

[16] A. Joerk, M. Ritter, N. Langguth, R. A. Seidel, D. Freitag, K.-H. Herrmann, A. Schaefgen, M. Ritter, M. Günther, C. Sommer, D. Braemer, J. Walter, C. Ewald, R. Kalff, J. R. Reichenbach, M. Westerhausen, G. Pohnert, O. W. Witte, K. Holthoff, Circ. Res.2019, 124, e101–e114.10.1161/CIRCRESAHA.118.314160Suche in Google Scholar

[17] S. Kotha, K. Lahiri, D. Kashinath, Tetrahedron2002, 58, 9633–9695.10.1016/S0040-4020(02)01188-2Suche in Google Scholar

[18] R. Martin, S. L. Buchwald, Acc. Chem. Res.2008, 41, 1461–1473.10.1021/ar800036sSuche in Google Scholar PubMed PubMed Central

[19] H. Doucet, Eur. J. Org. Chem.2008, 2013–2030.10.1002/ejoc.200700984Suche in Google Scholar

[20] F.-S. Han, Chem. Soc. Rev.2013, 42, 5270–5298.10.1039/c3cs35521gSuche in Google Scholar PubMed

[21] A. J. J. Lennox, G. C. Lloyd-Jones, Chem. Soc. Rev.2014, 43, 412–443.10.1039/C3CS60197HSuche in Google Scholar

[22] J. W. B. Fyfe, A. J. B. Watson, Synlett2015, 26, 1139–1144.10.1055/s-0034-1380324Suche in Google Scholar

[23] C. Li, D. Chen, W. Tang, Synlett2016, 27, 2183–2200.10.1055/s-0035-1562360Suche in Google Scholar

[24] J. P. G. Rygus, C. M. Crudden, J. Am. Chem. Soc.2017, 139, 18124–18137.10.1021/jacs.7b08326Suche in Google Scholar

[25] H.-O. Kalinowski, S. Berger, S. Braun, 13C-NMR-Spektroskopie, Georg Thieme, Stuttgart, New York, 1984, pp. 115–117.Suche in Google Scholar

[26] G. R. Fulmer, A. J. M. Miller, N. H. Sherdan, H. E. Gottlieb, A. Nudelman, B. M. Stoltz, J. E. Bercaw, K. I. Goldberg, Organometallics2010, 29, 2176–2179.10.1021/om100106eSuche in Google Scholar

[27] R. W. W. Hooft, Collect, Nonius KappaCCD Data Collection Software, Nonius BV, Delft (The Netherlands) 1998.Suche in Google Scholar

[28] Z. Otwinowski, W. Minor in Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A (Eds.: C. W. Carter, R. M. Sweet), Academic Press, New York, 1997, pp. 307–326.10.1016/S0076-6879(97)76066-XSuche in Google Scholar

[29] Sadabs (version 2.10), Bruker AXS Inc., Madison, WI (USA) 2002.Suche in Google Scholar

[30] G. M. Sheldrick, Acta Crystallogr.2008, A64, 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

[31] G. M. Sheldrick, Acta Crystallogr.2015, C71, 3–8.Suche in Google Scholar

[32] XP, Siemens Analytical X-Ray Instruments Inc., Karlsruhe (Germany) 1990; Madison, WI (USA) 1994.Suche in Google Scholar

[33] POV-Ray, Trademark of Persistence of Vision Raytracer Pty. Ltd., Williamstown, Victoria (Australia); Copyright Hallam Oaks Pty. Ltd., 2007.Suche in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/znb-2019-0125).


Received: 2019-08-08
Accepted: 2019-10-10
Published Online: 2019-11-20
Published in Print: 2020-02-25

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. In this Issue
  3. Laudatio/Preface
  4. Arndt Simon zum 80. Geburtstag gewidmet
  5. Research Articles
  6. High-temperature superconductors: underlying physics and applications
  7. Chemical resistance and chemical capacitance
  8. Investigations of the optical and electronic effects of silicon and indium co-doping on ZnO thin films deposited by spray pyrolysis
  9. Electrochemical synthesis of transition metal oxide nitrides with ε-TaN, δ-NbN and γ′-Mo2N structure type in a molten salt system
  10. Preferred selenium incorporation and unexpected interlayer bonding in the layered structure of Sb2Te3−xSex
  11. BOX A-type monopyrrolic heterocycles modified via the Suzuki-Miyaura cross-coupling reaction
  12. Cooperative activation of azides by an Al/N-based active Lewis pair – unexpected insertion of nitrogen atoms into C–Si bonds and formation of AlCN3 heterocycles
  13. Squares of gold atoms and linear infinite chains of Cd atoms as building units in the intermetallic phases REAu4Cd2 (RE=La–Nd, Sm) with YbAl4Mo2-type structure
  14. Synthesis and characterization of K5Sn2OF11
  15. Li vs. Zn substitution in Li17Si4 – Li17–εδZnεSi4 connecting the structures of Li21Si5 and Li17Si4
  16. Cs2Zn(CN)4: a first example of a non-cyano spinel of composition A2M(CN)4 with A=alkali metal and M=group 12 metal
  17. Magnetic and electronic properties of CaFeO2Cl
  18. A spatially separated [KBr6]5− anion in the cyanido-bridged uranium(IV) compound [U2(CN)3(NH3)14]5+[KBr6]5−·NH3
  19. Crystal structures of the tetrachloridoaluminates(III) of rubidium(I), silver(I), and lead(II)
  20. A new theoretical model for hexagonal ice, Ih(d), from first principles investigations
  21. Structural characterization and Raman spectrum of Cs[OCN]
  22. New cation-disordered quaternary selenides Tl2Ga2TtSe6 (Tt=Ge, Sn)
  23. The UV-phosphor strontium fluorooxoborate Sr[B5O7F3]:Eu
  24. Extending the knowledge on the quaternary rare earth nickel aluminum germanides of the RENiAl4Ge2 series (RE=Y, Sm, Gd–Tm, Lu) – structural, magnetic and NMR-spectroscopic investigations
  25. Structural diversity in Cd(NCS)2-3-cyanopyridine coordination compounds: synthesis, crystal structures and thermal properties
  26. Cation-anion pairs of niobium clusters of the type [Nb6Cl12(RCN)6][Nb6Cl18] (R=Et, nPr, iPr) with nitrile ligands RCN forming stabilizing inter-ionic contacts
  27. “Flat/steep band model” for superconductors containing Bi square nets
  28. La- and Lu-agardite – preparation, crystal structure, vibrational and magnetic properties
  29. A series of new layered lithium europium(II) oxoniobates(V) and -tantalates(V)
  30. The untypical high-pressure Zintl phase SrGe6
  31. A new ternary silicide GdFe1−xSi2 (x=0.32): preparation, crystal and electronic structure
  32. Lanthanide orthothiophosphates revisited: single-crystal X-ray, Raman, and DFT studies of TmPS4 and YbPS4
  33. A hexaniobate expanded by six [Hg(cyclam)]2+ complexes via Hg–O bonds yields a positively charged polyoxoniobate cluster
  34. Preliminary communication
  35. A hexaniobate expanded by six [Hg(cyclam)]2+ complexes via Hg–O bonds yields a positively charged polyoxoniobate cluster
Heruntergeladen am 30.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/znb-2019-0125/html
Button zum nach oben scrollen